Intera Atlas
Run match
Sites / Synexus
Is this you?

Request access for Synexus with your @trialmed.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.

Request account

Synexus

Unclaimed profile

Site Network · Manchester, United Kingdom (US operations) · ~185+ (global, 28+ US dedicated sites, 68 affiliate sites) sites

WebsiteLinkedInRank for protocol
Intera lens
ICP 8Lift (cardio sample) 0.05Recruit soph 0.57
Quality Scorecard (1–100)
Overall83Recruit85Ops80Sponsor88Ther80

Performance (observed)

Historical trials
495
Completed
325
Terminated/Withdrawn
62
Completion rate
84%
Active now
106
Phase 2
151
Phase 3
308
Realized enrollment
1,426,011
First study year
2002
Years active
24
Match confidence
high
Enrollment velocity (inf)
59,417

Therapeutic

Areas
Multiple therapeutic areas, early to late phase trials
Specialties
Multiple therapeutic areas
Breadth (conditions)
321
States
Georgia, Ohio, Texas, Utah (and others)

Recruitment (web observed)

Trial Finder
Yes
Patient database
Y (20+ million patient database, 450,000+ pre-registered)
Recruitment pages
Yes
Advertises recruitment
Yes
SEO
Strong clinical trial recruitment presence
Capability notes
World's largest site network (post-Radiant merger); access to 100+ million patients globally; established multi-site recruiting infrastructure

Relationships

Sponsors
Pfizer; Eli Lilly and Company; Janssen Research & Development, LLC; Merck Sharp & Dohme LLC; AbbVie; Novo Nordisk A/S
CROs
Covance; ICON plc; IQVIA Pvt. Ltd; PPD Development, LP; PPD, Part of Thermo Fisher Scientific
Owner / parent
PPD (acquired/integrated into PPD operations)
Acquisitions
Rebranded to Trialmed under PPD Group

Capacity & people

Investigators
—
Coordinators
—
CEO
Christophe Berthoux (noted 2017)

Tech & DCT

Builds tech
Builds Tech Internally
Home visits
Y (site mentions)
DCT / decentralized
Y (Global network, UK headquartered)
Tech stack
Proprietary CTMS, patient engagement platforms
Recruiting visible
Y

Notes

Synexus (now rebranded as Trialmed, part of PPD/Thermo Fisher scientific restructuring) is world's largest site network. 185 global sites, 1500 employees pre-integration. European-headquartered, integrated with US-based Radiant Research 2017. US operations: 28 dedicated sites, 68 affiliates. Multi-therapeutic area coverage. Note: site underwent major rebranding May-June 2025 from Synexus/PPD/Optimal brands to unified Trialmed. ClinicalTrials.gov signal: 2 recruiting trials across 4 location(s), states: Georgia, Ohio, Texas, Utah. Excellent Intera fit: massive scale, multi-site, proven enrollment capability, tech-forward.

Recommendation features (sample indication)

Ind fit 0.12Liftability 0.05Overall83

FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.